Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein

Globally, human respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in newborns, young children, and the elderly for which there is no vaccine. The RSV fusion (F) glycoprotein is a major target for vaccine development. Here, we describe a novel monoclonal antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Qingqing, Wang, Zhao, Ni, Fengyun, Chen, Xiaorui, Ma, Jianpeng, Patel, Nita, Lu, Hanxin, Liu, Ye, Tian, Jing-Hui, Flyer, David, Massare, Michael J., Ellingsworth, Larry, Glenn, Gregory, Smith, Gale, Wang, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366758/
https://www.ncbi.nlm.nih.gov/pubmed/30730999
http://dx.doi.org/10.1371/journal.pone.0210749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366758/
https://www.ncbi.nlm.nih.gov/pubmed/30730999
http://dx.doi.org/10.1371/journal.pone.0210749

Ejemplares similares